Counterfeiting in pharmaceuticals is grave since it has a direct impact on healt – Medicines are an integral part of our lives given the fact that we as humans are susceptible to various forms of illnesses. But would it be shocking to know that these same medicines we turn to for cures of ailments could rather become hazardous to our wellbeing and even be fatal on some occasions? We might not be aware that many of the drugs we consume are fake and highly detrimental to our well-being.
Pets, for most of us, are an integral part of our lives. Be it the cuteness of a pooch or the agility of a feline, the crisp in the twittering of birds or the calmness of fishes in the tank, the presence of pets in a household is tantamount to therapy that ushers in happiness and bliss. We are all privy to the role pets play in any household, from helping to increase our physical activities, which has become vital especially with remote working setups, to helping us deal with anxiety issues and depressions, pets are the miraculous creatures that not only warm the cockles of our hearts, but also take the cudgel of keeping our health in place. While they help in keeping us healthy and fit, there are occasions in which we inadvertently put their lives at risk.
The pharmaceutical industry has been one of the most profitable targets for counterfeiters for years; In recent times however, the activities of counterfeiters within the sector have increased by several hundred folds. According to a report from The World Economic Forum published in February 2015, counterfeit drugs have been identified as one of the biggest risks facing the world today.
Counterfeiting is a challenge faced by almost all industries – in Pharmaceuticals however, it is a more daunting one considering the enormous risk to lives it portends. What makes this more critical is the quick technological advancements by counterfeiters, it is therefore imperative that the entire pharma supply chain develops a more up-to-date and robust response to this menace.
Gray markets in pharmaceuticals remains a perpetual headache for stakeholders – The issues of drug abuse and addiction are not peculiar to just a few select countries; these are global problems faced by all countries of the world and incidentally, majority of these drugs are obtained from illegal black markets.